Kenneth Krogulski - 02 Dec 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
02 Dec 2024
Net transactions value
+$8,209
Form type
4
Filing time
30 Dec 2024, 19:41:52 UTC
Previous filing
05 Dec 2024
Next filing
04 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $552 +415 +0.15% $1.33 272,042 02 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $523 +415 +0.15% $1.26 272,457 03 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $506 +415 +0.15% $1.22 272,872 04 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $420 +350 +0.13% $1.20 273,222 05 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $498 +415 +0.15% $1.20 273,637 06 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $519 +415 +0.15% $1.25 274,052 09 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $489 +197 +0.07% $2.48 274,249 10 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $451 +197 +0.07% $2.29 274,446 11 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $431 +197 +0.07% $2.19 274,643 12 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $459 +197 +0.07% $2.33 274,840 13 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $690 +312 +0.11% $2.21 275,152 16 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $661 +312 +0.11% $2.12 275,464 17 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $683 +312 +0.11% $2.19 275,776 18 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $620 +266 +0.1% $2.33 276,042 19 Dec 2024 Direct F1
transaction CPIX Common Stock Purchase $707 +301 +0.11% $2.35 276,343 20 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.